SCHEMBL5845071

SCHEMBL5845071

CCc1nc(C2CCC(C(C)(C)C)CC2)n2nc(C3CCCC3)[nH]c(=O)c12

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 3/20 0.42
PDE1A P54750 2/20 0.39
PDE1B Q01064 2/20 0.39
PDE1C Q14123 2/20 0.39
KHK P50053 4/20 0.35
ADORA1 P30542 5/20 0.34
TMIGD3 P0DMS9 1/20 0.34
KMT2A Q03164 2/20 0.34
ADORA2B P29275 7/20 0.33
ADORA2A P29274 6/20 0.33
ADORA3 P0DMS8 2/20 0.32
MEN1 O00255 1/20 0.32
GMNN O75496 1/20 0.32
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.32
TSHR P16473 1/20 0.32
PMP22 Q01453 1/20 0.32
HIF1A Q16665 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5845631 0.97 PDE5A (0.38) PDE5APDE1APDE1BPDE1CKHK
SCHEMBL5883665 0.92 PDE5A (0.46) PDE5APDE1APDE1BPDE1CKHK
SCHEMBL5883962 0.92 PDE5A (0.46) PDE5APDE1APDE1BPDE1CKHK
SCHEMBL5883465 0.91 PDE5A (0.47) PDE5APDE1APDE1BPDE1CKHK
SCHEMBL5884000 0.90 PDE5A (0.44) PDE5APDE1APDE1BPDE1CKHK
SCHEMBL5884388 0.90 PDE5A (0.46) PDE5APDE1APDE1BPDE1CKHK
SCHEMBL5884346 0.90 PDE5A (0.46) PDE5APDE1APDE1BPDE1CKHK
SCHEMBL6388600 0.86 PDE5A (0.36) PDE5APDE1APDE1BPDE1CKHK
SCHEMBL5845685 0.84 PDE5A (0.38) PDE5APDE1APDE1BPDE1CKHK
SCHEMBL6394807 0.84 PDE5A (0.43) PDE5APDE1APDE1BPDE1CKHK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115602-B2 Heterocycles 3 BAYER AKTIENGESELLSCHAFT (DE) 2006-10-03 US disclosed
US-20050065153-A1 Novel heterocycles 3 BAYER AKTIENGESELLSCHAFT (DE) 2005-03-24 US disclosed
US-20030139415-A1 Novel heterocycles 3 BAYER HEALTHCARE AKTIENGESELLSCHAFT (DE) 2003-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030139415-A1 Novel heterocycles 3 NFATC1, NOD2, NFKBIA PDE5A 1993/4885PDE1A 3380/4885PDE1B 3869/4885
US-20050065153-A1 Novel heterocycles 3 NFATC1, NOD2, NFKBIA PDE5A 1993/4885PDE1A 3380/4885PDE1B 3869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.